Zosano Lays Off ~30% Of Its Workforce After FDA Rejection Of Migraine Drug Application
Zosano Pharma Corp (NASDAQ: ZSAN) is looking at strategic alternatives and
Looking Into Zosano Pharma’s Return On Capital Employed
According to data from Benzinga Pro, during Q4, Zosano Pharma's (NASDAQ:ZSAN) reported sales totaled $87.00 thousand. Despite a 19.58% increase in earnings, the company posted a loss of $6.97 million.
93 Biggest Movers From Friday
Gainers
Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.
50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87.
Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
FDA Rejects Zosano Pharma’s Application For Zolmitriptan Microneedle System Again, Shares Plunge
The FDA has issued a response letter to Zosano Pharma Corp (NASDAQ:
25 Stocks Moving in Monday’s Pre-Market Session
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
60 Biggest Movers From Yesterday
Gainers
US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash.